An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organization (DRDO), in collaboration with Dr Reddy's Laboratories (DRL), Hyderabad.